Isradipine-d3
Modify Date: 2024-01-14 12:36:41
Isradipine-d3 structure
|
Common Name | Isradipine-d3 | ||
|---|---|---|---|---|
| CAS Number | 1189959-59-8 | Molecular Weight | 374.40600 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H18D3N3O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Isradipine-d3Isradipine-d3 (PN 200-110-d3) is the deuterium labeled Isradipine. Isradipine (PN 200-110) is an orally active L-type calcium channel blocker. Isradipine, as a powerful peripheral vasodilator, is a dihydropyridine calcium antagonist with selective actions on the heart as well as the peripheral circulation. Isradipine is a potentially viable neuroprotective agent for Parkinson's disease[1][2][3]. |
| Name | 3-O-propan-2-yl 5-O-(trideuteriomethyl) 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate |
|---|---|
| Synonym | More Synonyms |
| Description | Isradipine-d3 (PN 200-110-d3) is the deuterium labeled Isradipine. Isradipine (PN 200-110) is an orally active L-type calcium channel blocker. Isradipine, as a powerful peripheral vasodilator, is a dihydropyridine calcium antagonist with selective actions on the heart as well as the peripheral circulation. Isradipine is a potentially viable neuroprotective agent for Parkinson's disease[1][2][3]. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
| Molecular Formula | C19H18D3N3O5 |
|---|---|
| Molecular Weight | 374.40600 |
| Exact Mass | 374.16700 |
| PSA | 103.55000 |
| LogP | 2.91100 |
| Esradin-d3 |
| Prescal-d3 |
| Clivoten-d3 |
| DynaCirc-d3 |
| Isrodipine-3 |
| Isradipine-d3 |
| Lomir-d3 |
| [2H3]-Isradipine |